Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 704 Neoplasms 621 Prostatic Neoplasms 319 Lung Neoplasms 314 Colorectal Neoplasms 284 Carcinoma, Non-Small-Cell Lung 257 Pancreatic Neoplasms 181 Carcinoma, Hepatocellular 172 Stomach Neoplasms 141 Multiple Myeloma 128 Ovarian Neoplasms 123 Melanoma 118 Colonic Neoplasms 114 Brain Neoplasms 111 Hematologic Neoplasms 107 Head and Neck Neoplasms 106 Urinary Bladder Neoplasms 104 Leukemia, Myeloid, Acute 102 Esophageal Neoplasms 101 Disease 100 Uterine Cervical Neoplasms 91 Liver Neoplasms 91 Neoplasm Metastasis 90 Lymphoma 86 Rectal Neoplasms 85 Precursor Cell Lymphoblastic Leukemia-Lymphoma 84 Endometrial Neoplasms 79 Carcinoma, Renal Cell 74 Leukemia 65 Recurrence 63

Interventions

trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × HER2-positive Gastric Cancer × 1 year × Clear all

NCT06846996 2025-07-08

RECOVER

Daiichi Sankyo

Gastrointestinal

HER2-positive Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡